October 23, 2019 10:30 AM EDT

EY vet set to replace retiring Amgen CFO Meline

Natalie Grover

Reporter

Ahead of its third-quarter results next week, Amgen on Tuesday disclosed the planned retirement of David Meline, who has served as the company’s chief …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

EY vet set to replace retiring Amgen CFO Meline

Natalie Grover

Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Will CRISPR matter?

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

EY vet set to re­place re­tir­ing Am­gen CFO Meline

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

EY vet set to replace retiring Amgen CFO Meline